Almac Discovery Announce ALM201 Poster Presentation at 2017 European Society for Medical Oncology Congress
Almac Discovery, a biopharmaceutical company focused on discovering and identifying innovative therapeutics for the treatment of cancer, will present highlights of the safety data from the ALM201 Phase I trial at the ESMO congress in Madrid, Spain on September 8 – 12 2017.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.